Surgical Sutures

Surgical Sutures Market Outlook

The global surgical sutures market is projected to reach approximately USD 5.8 billion by 2035, growing at a compound annual growth rate (CAGR) of around 6.5% from 2025 to 2035. The increasing number of surgical procedures worldwide, coupled with advancements in suture technology, is a significant growth factor for the market. Additionally, the rising prevalence of chronic diseases requiring surgical intervention is propelling the demand for surgical sutures. The growing awareness of minimally invasive surgical techniques and the increasing number of hospitals and ambulatory surgical centers are also contributing to the market's expansion. Furthermore, government initiatives to improve healthcare infrastructure in emerging economies are expected to support the growth of the surgical sutures market.

Growth Factor of the Market

One of the primary growth factors for the surgical sutures market is the rising incidence of chronic diseases, including cardiovascular diseases, diabetes, and cancer, which often necessitate surgical interventions. As the global population ages, the demand for surgical procedures increases, creating an uptick in the need for effective suturing materials. Additionally, advancements in medical technology, including the development of innovative suturing techniques and biodegradable materials, are enhancing the performance of surgical sutures. The growing awareness and preference for minimally invasive surgeries also contribute significantly to the market, as these procedures often require specialized sutures for optimal outcomes. Furthermore, the expansion of healthcare facilities and the increased number of trained healthcare professionals are poised to bolster the market, enabling broader access to surgical interventions that utilize sutures.

Key Highlights of the Market

• The market is expected to grow at a CAGR of 6.5% from 2025 to 2035.
• North America accounts for the largest share of the market due to advanced healthcare infrastructure.
• Absorbable sutures are gaining popularity due to their convenience and reduced need for suture removal.
• Increased government funding for healthcare in emerging economies is driving market growth.
• Technological advancements are leading to the development of innovative suture materials and designs.

By Product Type

Absorbable Sutures:

Absorbable sutures are a dominant segment in the surgical sutures market, primarily due to their convenience and effectiveness in wound healing. These sutures are designed to degrade and be absorbed by the body over time, eliminating the need for removal and reducing the risk of infection. They are widely used in internal surgeries and for closing soft tissue wounds in various medical specialties. The increasing preference for absorbable sutures in surgical procedures further supports their growth in the market, driven by advancements in bioengineering that enhance their absorption rate and biocompatibility. Additionally, the rising number of surgeries in outpatient settings where quick recovery and minimal follow-up are essential is contributing to the popularity of absorbable sutures.

Non-absorbable Sutures:

Non-absorbable sutures hold a significant share of the surgical sutures market due to their durability and strength. These sutures are typically made from materials such as nylon, polyester, and polypropylene, making them ideal for applications that require long-term support. They are commonly used in orthopedic surgeries, where stability is crucial, and in procedures involving skin closure where suture removal is routine. The increasing number of complex surgeries and the demand for high-strength sutures are driving their market growth. Furthermore, innovations in non-absorbable sutures, including the development of coated variants that reduce tissue drag and improve handling, are enhancing their application across various surgical specialties.

Barbed Sutures:

Barbed sutures are emerging as a key segment in the surgical sutures market due to their unique design that eliminates the need for knots. The barbs on these sutures allow for secure fixation within the tissue, which is particularly advantageous in minimally invasive surgeries. They reduce the time taken for suturing, thereby improving surgical efficiency and patient outcomes. The increasing adoption of minimally invasive surgical techniques across various medical fields is driving the demand for barbed sutures. Moreover, advancements in manufacturing processes are leading to the development of new materials and designs that enhance the functionality and application of barbed sutures.

Monofilament Sutures:

Monofilament sutures, made from a single strand of material, are known for their smooth passage through tissue, which reduces the risk of infection and irritation. This type of suture is highly resistant to bacterial colonization, making it a preferred choice in surgeries where infection risk is a concern. Monofilament sutures are commonly used in various surgical applications, including cardiovascular and ophthalmic surgeries. The growing preference for sutures that minimize tissue trauma and promote faster healing is driving the demand for monofilament sutures. Additionally, innovations in monofilament suture technology are expanding their applications, further enhancing their market presence.

Braided Sutures:

Braided sutures are characterized by their multi-strand construction, which provides enhanced strength and flexibility. These sutures are commonly used in surgical procedures that require the ability to withstand tension and stress, such as orthopedic and general surgeries. The intrinsic nature of braided sutures allows for better knot security and handling, making them a popular choice among surgeons. The rising prevalence of surgical procedures, particularly in trauma cases, is driving the demand for braided sutures. Furthermore, ongoing advancements in braiding technology are leading to the development of sutures with improved properties, including reduced tissue drag and enhanced biocompatibility, further boosting their market growth.

By Application

Cardiovascular Surgery:

The application of surgical sutures in cardiovascular surgery is critical, as these procedures often involve delicate tissues that require precise closure techniques. The growing incidence of cardiovascular diseases necessitates an increase in surgical interventions, driving the demand for high-quality sutures designed specifically for this purpose. Sutures used in cardiovascular applications must exhibit exceptional strength and biocompatibility, as they often come into contact with blood vessels and cardiac tissues. Innovations in suture materials, such as the development of bioresorbable options, are enhancing the effectiveness of sutures in cardiovascular surgeries. The increasing number of coronary and vascular surgeries being performed worldwide further supports the growth of this application segment.

Orthopedic Surgery:

In orthopedic surgery, surgical sutures play a vital role in repairing musculoskeletal injuries and reconstructing damaged tissues. The rising prevalence of sports-related injuries and an aging population are contributing to the increased demand for orthopedic surgeries, thereby driving the market for sutures in this application. Sutures used in orthopedic procedures require superior tensile strength and the ability to withstand high-stress conditions, which is leading to the adoption of advanced materials and designs. Furthermore, the trend toward minimally invasive orthopedic surgery is also influencing the choice of sutures, as specialized sutures that provide secure fixation without causing significant tissue damage become more desirable.

Gynecological Surgery:

The application of surgical sutures in gynecological surgery is essential for various procedures, including hysterectomies, cesarean sections, and pelvic surgeries. The increasing rates of gynecological surgeries, driven by a higher prevalence of reproductive health issues, are propelling the demand for specialized sutures. Surgical sutures used in this field must be compatible with delicate tissues and promote optimal healing. Additionally, the growing emphasis on patient safety and comfort during surgical procedures is influencing the selection of sutures, with a preference for absorbable options that minimize the need for additional follow-up care. The development of innovative suturing materials is also enhancing the efficacy of surgical interventions in gynecology.

Ophthalmic Surgery:

Ophthalmic surgery is another key application for surgical sutures, as they are used in various procedures involving the eye, such as cataract surgery and corneal repairs. The demand for sutures in this field is driven by the increasing prevalence of eye diseases and the growing number of ophthalmic surgeries performed globally. Sutures used in ophthalmic applications must be finely crafted to accommodate the delicate tissues of the eye and provide minimal scarring. Innovations in suture technology, including the development of ultra-fine sutures and advanced materials, are poised to enhance surgical outcomes and patient satisfaction in ophthalmic surgeries. The increasing focus on improving surgical techniques and reducing recovery times is further driving the demand for specialized sutures in this segment.

General Surgery:

General surgery encompasses a wide range of surgical procedures, making it a significant application for surgical sutures. The versatility of sutures allows them to be utilized in various conditions, from hernia repairs to gastrointestinal surgeries. The rising number of surgical interventions and the demand for reliable wound closure mechanisms are driving the growth of the surgical sutures market within this application segment. Additionally, advancements in suture technology, such as the development of antimicrobial sutures, are enhancing the effectiveness and safety of surgical procedures. As healthcare providers strive to improve surgical outcomes and reduce post-operative complications, the demand for quality surgical sutures in general surgery is expected to grow.

By Distribution Channel

Hospitals:

Hospitals are one of the primary distribution channels for surgical sutures, accounting for a significant portion of the market. The majority of surgical procedures take place in hospitals, where a wide range of suturing materials is readily available to meet the diverse needs of surgical teams. The increasing number of surgical cases and the demand for advanced suturing options are driving the procurement of surgical sutures in hospital settings. Hospitals are also investing in high-quality sutures to improve patient outcomes and reduce the incidence of complications associated with improper wound closure. As surgical volumes continue to rise, the reliance on hospitals as a key distribution channel for surgical sutures is expected to remain strong.

Ambulatory Surgical Centers:

Ambulatory surgical centers (ASCs) are becoming an increasingly important distribution channel for surgical sutures, reflecting the growing trend towards outpatient surgeries. These centers provide a convenient and cost-effective alternative to traditional hospital settings for certain surgical procedures, which is leading to an increased demand for surgical sutures tailored for outpatient use. The rise in minimally invasive procedures performed in ASCs also necessitates specialized sutures that promote quick recovery and reduced post-operative care. As patients seek more accessible surgical options, ASCs are poised to capture a larger share of the surgical sutures market, further supporting growth in this distribution channel.

Specialty Clinics:

Specialty clinics, which focus on specific medical fields such as orthopedics, gynecology, and ophthalmology, represent a growing distribution channel for surgical sutures. These clinics provide targeted care and treatment, often utilizing specialized suturing techniques and materials tailored for their patient populations. The increasing trend towards specialization in healthcare is driving the demand for surgical sutures in these settings, as clinics strive to enhance patient outcomes through advanced surgical practices. Furthermore, the emphasis on personalized healthcare is leading specialty clinics to select sutures that align with their specific surgical protocols, bolstering their role in the overall surgical sutures market.

Online Sales:

Online sales are an emerging distribution channel for surgical sutures, reflecting the broader trend of digital transformation in healthcare. The convenience of online procurement allows hospitals, clinics, and even individual practitioners to access a wide range of suturing products efficiently. As healthcare stakeholders seek to streamline their supply chains and reduce costs, the shift towards online purchasing is gaining traction. Additionally, online platforms provide a wealth of information on product specifications and user reviews, enabling buyers to make informed decisions. As trust in online purchasing continues to grow within the healthcare industry, online sales are expected to contribute significantly to the overall surgical sutures market.

By Material Type

Polyglactin:

Polyglactin is one of the most widely used materials for absorbable surgical sutures, known for its excellent tensile strength and predictable absorption rate. It is a synthetic polymer that undergoes hydrolysis, leading to gradual absorption in the body. This property makes polyglactin sutures ideal for applications where sutures need to provide support during the healing process without requiring removal. The increased preference for absorbable sutures in various surgical applications, particularly in gynecological and general surgery, is driving the demand for polyglactin sutures. Furthermore, advancements in the manufacturing process are enhancing the biocompatibility and performance of polyglactin sutures, further solidifying their position in the market.

Polydioxanone:

Polydioxanone sutures are another important type of absorbable suture known for their high tensile strength and extended absorption period. These sutures are particularly beneficial in procedures that require prolonged support, such as cardiac and orthopedic surgeries. The ability of polydioxanone sutures to maintain strength for an extended period before absorbing makes them a preferred choice among surgeons. With the increasing number of complex surgeries and the demand for reliable suturing options, the utilization of polydioxanone sutures is expected to grow significantly. Additionally, ongoing research and development efforts aimed at enhancing the properties of polydioxanone sutures contribute to their expanding applications across various surgical specialties.

Polyglycolic Acid:

Polyglycolic acid (PGA) sutures are biodegradable and absorbable, making them ideal for various surgical applications. They are known for their quick absorption rate and high tensile strength, which support effective wound healing. PGA sutures are widely utilized in soft tissue approximation and are a popular choice in general and orthopedic surgeries. The growing preference for sutures that promote faster healing and reduce the need for follow-up procedures is driving the demand for PGA sutures. Additionally, the development of hybrid sutures that combine PGA with other materials is expanding their application range, further boosting their presence in the surgical sutures market.

Catgut:

Catgut sutures are made from natural fiber derived from the intestines of sheep or goats, making them a traditional option in the surgical sutures market. Despite their natural origin, catgut sutures possess effective absorbable properties, making them suitable for many surgical applications, particularly in areas requiring minimal tissue irritation. While their use has declined due to the availability of synthetic alternatives, catgut sutures are still preferred in certain situations, particularly in rural and resource-limited settings. The resurgence of interest in natural materials and their potential advantages in specific surgical fields is leading to a renewed focus on catgut sutures, although their overall market share remains limited compared to synthetic options.

Nylon:

Nylon sutures are widely used as non-absorbable sutures due to their excellent strength and durability. They are suitable for use in various surgical applications, including skin closure, general surgery, and orthopedic procedures. The key advantage of nylon sutures is their ability to provide long-term support, which is vital in many surgical situations where tissue integrity is crucial. Their availability in both monofilament and braided forms allows for versatility in surgical techniques. The growing number of surgical interventions and the demand for reliable long-lasting sutures are driving the market for nylon sutures. Additionally, ongoing innovations in nylon suture technology are enhancing their performance and expanding their applications.

By Region

North America holds a significant share of the global surgical sutures market, primarily driven by advanced healthcare infrastructure, high surgical volumes, and the presence of leading manufacturers in the region. The increasing incidence of chronic diseases, along with a growing aging population, is propelling the need for surgical interventions, thereby boosting demand for surgical sutures. The market in North America is projected to grow at a CAGR of approximately 6.2% in the coming years. Additionally, the region experiences continuous advancements in suture technology, leading to the development of innovative products tailored for various surgical applications, further enhancing market growth.

Europe is also a prominent region in the surgical sutures market, characterized by a well-established healthcare system and a strong focus on surgical innovations. The increasing prevalence of chronic conditions and the rising number of surgical procedures are significant factors driving the market in Europe. The region is expected to witness steady growth, supported by factors such as the growing demand for minimally invasive surgeries and advancements in suture materials. The market in Europe is projected to grow at a CAGR of around 6.1%, reflecting favorable market conditions and ongoing investments in healthcare infrastructure and technology.

Opportunities

The surgical sutures market presents numerous opportunities driven by technological advancements in the medical field. One of the notable opportunities lies in the development of innovative suturing materials and techniques that enhance surgical outcomes. The increasing focus on minimally invasive surgical procedures opens up avenues for specialized sutures designed to facilitate quicker recovery and reduce post-operative complications. Moreover, advancements in biocompatible and biodegradable materials are paving the way for new product development, which is expected to cater to a broader range of surgical applications. As healthcare providers continue to prioritize patient safety and satisfaction, the demand for high-quality surgical sutures that align with these priorities is set to rise.

The global expansion of healthcare infrastructure, particularly in emerging economies, is another significant opportunity for the surgical sutures market. As countries invest in improving their healthcare systems and increasing access to surgical services, the demand for surgical sutures is likely to experience substantial growth. Additionally, the rising awareness of advanced surgical techniques and the benefits of modern suturing materials among healthcare professionals and patients further bolster this opportunity. Collaborations between manufacturers and healthcare providers to develop tailored solutions for specific surgical needs will also play a crucial role in leveraging these growth prospects in the surgical sutures market.

Threats

Despite the positive growth outlook for the surgical sutures market, several threats could impede its progress. One significant threat is the increasing competition among manufacturers, leading to price wars that may affect profit margins. As more players enter the market, particularly in developing regions, the pressure to lower pricing while maintaining quality can pose challenges for established companies. Additionally, the potential for product recalls and regulatory scrutiny regarding the safety and efficacy of surgical sutures could create setbacks for manufacturers. Stringent regulatory requirements and the need for comprehensive testing can increase the time and cost associated with bringing new products to market, further complicating the competitive landscape.

Another key threat to the surgical sutures market is the growing preference for alternative wound closure methods, such as adhesive strips and staples. These alternatives may offer faster application and reduced complications compared to traditional suturing techniques, leading to a decline in demand for surgical sutures. Additionally, the increasing focus on reducing surgical costs may prompt healthcare providers to adopt less expensive alternatives, potentially impacting the market for sutures. As healthcare trends continue to evolve, manufacturers must remain agile and responsive to changes in surgical practices and preferences to sustain their market share.

Competitor Outlook

• Ethicon, Inc.
• Medtronic plc
• Boston Scientific Corporation
• Allergan, Inc.
• Smith & Nephew plc
• Stryker Corporation
• CooperSurgical, Inc.
• 3M Company
• Teleflex Incorporated
• Conmed Corporation
• Cardinal Health, Inc.
• DePuy Synthes
• Integra LifeSciences Corporation
• Pfizer Inc.
• Vyaire Medical, Inc.

The competitive landscape of the surgical sutures market is characterized by the presence of key players that are continually striving to innovate and enhance their product offerings. Major companies such as Ethicon, Inc., a subsidiary of Johnson & Johnson, is a leading player known for its extensive range of surgical sutures, including absorbable and non-absorbable options. Ethicon invests heavily in research and development to introduce innovative suturing technologies and materials, solidifying its position in the market. Similarly, Medtronic plc, known for its medical devices and technologies, has made significant advancements in suturing techniques, positioning itself as a leader in the surgical sutures sector.

Boston Scientific Corporation is another major competitor, focusing on developing advanced surgical sutures and related technologies. The company's strategic acquisitions and partnerships have allowed it to expand its product portfolio and reach. Additionally, Smith & Nephew plc is known for its commitment to innovation within the surgical space, offering a range of suturing solutions tailored to meet the needs of various surgical specialties. The company’s focus on enhancing patient outcomes through its products further contributes to its competitive edge in the surgical sutures market. Moreover, Stryker Corporation, recognized for its orthopedic and surgical products, has leveraged its expertise in this domain to develop suturing solutions that cater to orthopedic and trauma surgeries.

Other notable players such as Teleflex Incorporated and Cardinal Health, Inc. are also making inroads in the surgical sutures market through their focus on quality, safety, and innovation. These companies are continually exploring new materials, designs, and technologies to improve the performance and efficacy of surgical sutures. With the increasing demand for advanced surgical solutions and the ongoing evolution of surgical practices, these key players are set to play a crucial role in shaping the future of the surgical sutures market.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 3M Company
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Pfizer Inc.
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 DePuy Synthes
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Ethicon, Inc.
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Medtronic plc
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Allergan, Inc.
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Conmed Corporation
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Smith & Nephew plc
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Stryker Corporation
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 CooperSurgical, Inc.
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Vyaire Medical, Inc.
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Cardinal Health, Inc.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Teleflex Incorporated
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Boston Scientific Corporation
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Integra LifeSciences Corporation
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Surgical Sutures Market, By Application
    • 6.1.1 Cardiovascular Surgery
    • 6.1.2 Orthopedic Surgery
    • 6.1.3 Gynecological Surgery
    • 6.1.4 Ophthalmic Surgery
    • 6.1.5 General Surgery
  • 6.2 Surgical Sutures Market, By Product Type
    • 6.2.1 Absorbable Sutures
    • 6.2.2 Non-absorbable Sutures
    • 6.2.3 Barbed Sutures
    • 6.2.4 Monofilament Sutures
    • 6.2.5 Braided Sutures
  • 6.3 Surgical Sutures Market, By Material Type
    • 6.3.1 Polyglactin
    • 6.3.2 Polydioxanone
    • 6.3.3 Polyglycolic Acid
    • 6.3.4 Catgut
    • 6.3.5 Nylon
  • 6.4 Surgical Sutures Market, By Distribution Channel
    • 6.4.1 Hospitals
    • 6.4.2 Ambulatory Surgical Centers
    • 6.4.3 Specialty Clinics
    • 6.4.4 Online Sales

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Surgical Sutures Market by Region
  • 10.6 Middle East & Africa - Market Analysis
    • 10.6.1 By Country
      • 10.6.1.1 Middle East
      • 10.6.1.2 Africa

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Surgical Sutures market is categorized based on

By Product Type

• Absorbable Sutures
• Non-absorbable Sutures
• Barbed Sutures
• Monofilament Sutures
• Braided Sutures

By Application

• Cardiovascular Surgery
• Orthopedic Surgery
• Gynecological Surgery
• Ophthalmic Surgery
• General Surgery

By Distribution Channel

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Online Sales

By Material Type

• Polyglactin
• Polydioxanone
• Polyglycolic Acid
• Catgut
• Nylon

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Ethicon, Inc.
• Medtronic plc
• Boston Scientific Corporation
• Allergan, Inc.
• Smith & Nephew plc
• Stryker Corporation
• CooperSurgical, Inc.
• 3M Company
• Teleflex Incorporated
• Conmed Corporation
• Cardinal Health, Inc.
• DePuy Synthes
• Integra LifeSciences Corporation
• Pfizer Inc.
• Vyaire Medical, Inc.